AlphaQuest’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,236
Closed -$97.7K 406
2025
Q4
$97.7K Sell
1,236
-6,040
-83% -$474K 0.01% 1750
2025
Q3
$582K Buy
7,276
+4,460
+158% +$380K 0.04% 696
2025
Q2
$256K Sell
2,816
-2,334
-45% -$213K 0.03% 976
2025
Q1
$483K Sell
5,150
-6,965
-57% -$624K 0.05% 539
2024
Q4
$1.1M Sell
12,115
-19,714
-62% -$1.88M 0.15% 209
2024
Q3
$3.3M Buy
31,829
+13,066
+70% +$1.33M 0.29% 31
2024
Q2
$1.82M Buy
18,763
+11,410
+155% +$1.05M 0.25% 108
2024
Q1
$662K Sell
7,353
-6,158
-46% -$522K 0.12% 299
2023
Q4
$1.08M Buy
+13,511
New +$1.02M 0.23% 123

Other funds holding CL

AlphaQuest's CL Position: Q1 2026 in Review

AlphaQuest sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 1,236 shares — an estimated $97.7K sold.

AlphaQuest first reported a position in CL in Q4 2023 and held it in 9 quarters. The position peaked at $3.3M in Q3 2024. 1,964 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • AlphaQuest reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 1,236 Colgate-Palmolive shares in Q1 2026, an estimated $97.7K.
  • AlphaQuest first reported a position in Colgate-Palmolive in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Colgate-Palmolive position peaked at $3.3M in Q3 2024.
  • 1,964 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.